Measuring levels of the protein GFAP in blood can help to predict disability progression among MS patients who don't experience relapses.
#ECTRIMS2022 – Evobrutinib Reduces MS Relapses Over 3 Years | Long-term Use of MS Therapy Candidate Safe, Effective: Trial Data
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
Simoa, Sensitive Biomarker Technology, May Help Predict MS Activity
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
Epstein-Barr virus may be leading cause of multiple sclerosis
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.